Zachariah McIver, D.O., Ph.D.

Zachariah McIver, D.O., Ph.D.

Former Chief Medical OfficeratJanux Therapeutics· In the 2025 proxy

Pay in FY2025Janux Therapeutics stock -74.2% the same year

Zachariah McIver, D.O., Ph.D. was paid $4.6M in FY2025 (Dec). Janux Therapeutics stock fell 74.2% that year.

Pay$100 in the stock at the end of FY24 → $26
Pay is from the Summary Compensation Table of each Janux Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Janux TherapeuticsPublic company · 1 yr
    • Former Chief Medical Officer2025 – Present · 1 yrStock in role -68%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?